DUBLIN–(BUSINESS WIRE)–The “Regulatory Report: The E-Cigarette Market in Kyrgyzstan, March 2022” report has been added to ResearchAndMarkets.com’s offering.
This report provides an analysis of the current regulatory regime for e-cigarettes in the country, which have been updated in 2022, with some further new rules and taxation due in 2022 and 2023.
Regulations concerning e-cigarettes in Kyrgyzstan were first introduced in 2021, equating vaping products with traditional tobacco products. It covers all aspects from labeling and product restrictions to retail and advertising regulations.
Key Topics Covered:
1 Executive Summary
2 Outlook
3 Kyrgyzstan: The Basics
4 National Regulatory Framework
5 Age Restrictions
6 Product Restrictions
7 Labelling and Packaging
8 Obligation to Notify
9 Retail Channel Restrictions
10 Public Usage
11 Advertising and Marketing
12 Taxation
For more information about this report visit https://www.researchandmarkets.com/r/ls8pu1
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
ZHENGZHOU, China--(BUSINESS WIRE)--In central China’s Zhengzhou city, visiting museums has become a new trend of…
Mollie Pearce, star of the UK reality TV show ‘The Traitors’ who was diagnosed with…
QBA 2024 Announces 35 Finalists Competing for Hong Kong's Highest Honour in the Building Industry…
SINGAPORE - Media OutReach Newswire - 17 May 2024 - UXLINK, the Web3 social platform…
DUBLIN--(BUSINESS WIRE)--The "Australia Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast to…
Three-part podcast interview features The mechanism of action of ANKTIVA® activating NK cells, Killer T…